Broadridge launches on-chain governance platform for tokenized equities

Broadridge Financial Solutions Inc. (NYSE: BR) announced the launch of a governance platform supporting digital assets, enabling proxy voting and corporate actions for tokenized securities alongside traditional holdings.

The platform allows public companies, broker-dealers, wealth managers, and investors to manage governance activities across both conventional and tokenized securities within existing workflows. Galaxy (NASDAQ: GLXY), the first U.S. public company to issue native tokenized equity on a public blockchain, will use the platform for its annual shareholder meeting in May.

The system records proxy voting on Broadridge's Avalanche-based infrastructure and distributes results across multiple blockchains. Investors can receive materials, confirm holdings, and submit votes through digital wallets with transparent record-keeping.

"Proxy voting is a core feature of equity ownership and bringing proxy voting on-chain for a public company is not theoretical anymore," said Mike Novogratz, Galaxy's founder and CEO.

Broadridge's solution consolidates voting across registered, beneficial, and tokenized holdings into a unified view for issuers. The platform supports both issuer-sponsored and third-party-sponsored tokenized securities.

The company currently processes $8 trillion in tokenized assets monthly and handles over 7 billion communications annually. Its platforms underpin daily trading of over $15 trillion in tokenized and traditional securities globally.

"Ensuring accurate, scalable, and cost-effective governance has never been more critical to supporting the growth of tokenized equities," said Tim Gokey, Broadridge's CEO.

The announcement represents an expansion of Broadridge's existing tokenization capabilities as digital asset adoption increases across financial services.

You May Also Be Interested In

• Aflac (AFL) files mixed shelf
• Popular stocks with increasing option volume: SPCX MU INTC NFLX PLTR SOFI MSTR AMC IBM SMCI HOOD
• Helus Pharma prices $50M share offering at $4.85 per share